8-K: Chemed's VITAS Healthcare to Acquire Covenant Care Hospice Assets for $85 Million

Chemed Corporation's VITAS Healthcare is set to acquire hospice assets and an assisted living facility from Covenant Care for $85 million, expanding its reach in Florida and Alabama.

Summary

• Chemed Corporation, through its subsidiary VITAS Healthcare, has agreed to purchase substantially all hospice assets and an assisted living facility from Covenant Care for $85 million.
• The acquisition includes hospice operations in several markets across the Florida panhandle and Alabama, including Pensacola, Tallahassee, and Mobile.
• The transaction is structured as an asset purchase and is expected to close in the second quarter of 2024, pending regulatory and other approvals.
• The purchase will be funded using Chemed's existing cash reserves.

Sentiment

Score: 8

Explanation: The document conveys a positive sentiment due to the strategic acquisition, which is expected to benefit both companies. The language used by management is optimistic and forward-looking.

Positives

• The acquisition will expand VITAS Healthcare's market presence in Florida and Alabama.
• Covenant Care has a 44-year history of providing high-quality, patient-centered care.
• The transaction is expected to benefit both organizations by aligning their missions and cultures.
• Covenant Care will be able to focus on improving healthcare in the communities they serve by supporting new solutions and filling gaps in the care delivery system.
• The acquisition will allow Covenant Care to expand its reach and impact by supporting solutions across the health care continuum with special focus on behavioral health, pediatrics, and veteran care.

Risks

• The transaction is subject to regulatory and other approvals, which could potentially delay or prevent the closing.
• There is a risk that the integration of Covenant Care's operations into VITAS Healthcare may present challenges.

Future Outlook

The transaction is expected to close in the second quarter of 2024, subject to regulatory and other approvals. Chemed does not assume any obligation to update forward-looking statements based on unanticipated events or changed expectations.

Management Comments

• Nick Westfall, Chairman and CEO of VITAS Healthcare, stated that VITAS is looking forward to building upon Covenant Care's legacy by following their key values of putting patients, families, and team members first.
• Jeff Mislevy, President and CEO of Covenant Care, stated that the transaction allows the organization to broaden and deepen its focus on improving healthcare for the communities they serve.
• Dr. Rodney Guttmann, Chairman of the Covenant Care Board of Directors, stated that the acquisition allows them to continue their mission of providing support for patient care and family grief.

Industry Context

This acquisition reflects a trend of consolidation within the healthcare industry, particularly in the hospice care sector, where larger providers are seeking to expand their geographic reach and service offerings.

Comparison to Industry Standards

• The acquisition of Covenant Care by VITAS Healthcare is consistent with the trend of consolidation in the hospice industry, where larger players like VITAS are acquiring smaller regional providers to expand their market share.
• Other major players in the hospice industry include companies like Amedisys and LHC Group, which have also grown through acquisitions.
• The $85 million purchase price is within the typical range for acquisitions of this size in the hospice sector, although specific valuations can vary based on factors such as patient volume, geographic location, and profitability.

Stakeholder Impact

• Shareholders of Chemed are likely to view the acquisition positively as it expands VITAS's market presence.
• Employees of Covenant Care may be impacted by the acquisition, with some potentially joining VITAS.
• Patients and families served by Covenant Care will continue to receive hospice care, now under the VITAS brand.
• The communities served by Covenant Care will benefit from the continued provision of hospice and palliative care.

Next Steps

• The parties will seek to close the transaction in the second quarter of 2024.
• Regulatory and other approvals will be obtained.

Key Dates

Keywords

VITAS Healthcare, Chemed Corporation, Hospice, Acquisition, Covenant Care, Healthcare, Asset Purchase, Florida, Alabama